Sort   by:  
 Page size 
UnknownAlphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.
Not available
S-EPMC4314072 | biostudies-literature
UnknownBiotech's role in advancing HIV vaccine development.
Not available
S-EPMC11321102 | biostudies-literature
UnknownMetabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.
Not available
S-EPMC1567909 | biostudies-literature
TranscriptomicsTranscription profiling of hepatocytes from mice that are hyperglycaemic, obese and insulin resistant as a result of being fed a high fat diet
Effect of high fat diet feeding on gene expression
ORGANISM(S): Mus musculus 
2006-11-15 | E-MEXP-893 | biostudies-arrayexpress
UnknownA Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.
Not available
S-EPMC5319954 | biostudies-literature
UnknownEnvelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
Not available
S-EPMC6492543 | biostudies-literature
UnknownBoosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
Not available
S-EPMC4871571 | biostudies-literature
Sort   by:  
 Page size